Helicobacter pylori eradication and its implications for the future - PubMed (original) (raw)
Review
Helicobacter pylori eradication and its implications for the future
M J Blaser. Aliment Pharmacol Ther. 1997 Apr.
Abstract
It has become evident that at least some strains of Helicobacter pylori are pathogenic for humans. However, H. pylori are highly diverse and at least part of this variation involves characteristics related to pathogenicity. A large amount of evidence suggests that H. pylori infection of humans is ancient, and in general, the interaction is not terribly destructive. However, we should try to understand better the risks associated with infection with particular H. pylori strains, and limit treatment to those situations in which the indications for eradicating H. pylori are clear-cut. It is entirely possible that some H. pylori strains are commensals, and that others are symbionts. Eradicating those infections could ultimately cause more harm than good. It is too early to reach firm conclusions about whether all H. pylori infections need to be eradicated.
Similar articles
- Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan.
Suzuki H, Nishizawa T, Tsugawa H, Hibi T. Suzuki H, et al. Keio J Med. 2012;61(4):109-19. doi: 10.2302/kjm.2012-0001-re. Keio J Med. 2012. PMID: 23324305 Review. - Treatment of gastric marginal zone lymphoma of MALT type.
Stathis A, Bertoni F, Zucca E. Stathis A, et al. Expert Opin Pharmacother. 2010 Sep;11(13):2141-52. doi: 10.1517/14656566.2010.497141. Expert Opin Pharmacother. 2010. PMID: 20586708 Review. - Helicobacter pylori infection and surgical disease---part I.
Stabile BE, Smith BR, Weeks DL. Stabile BE, et al. Curr Probl Surg. 2005 Nov;42(11):756-89. doi: 10.1067/j.cpsurg.2005.08.006. Curr Probl Surg. 2005. PMID: 16310017 Review. No abstract available. - Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ, Kim N, Paik JH, Kim JM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC. Choi YJ, et al. Helicobacter. 2013 Jun;18(3):197-205. doi: 10.1111/hel.12033. Epub 2013 Jan 11. Helicobacter. 2013. PMID: 23305046
Cited by
- Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
Brennan CA, Garrett WS. Brennan CA, et al. Nat Rev Microbiol. 2019 Mar;17(3):156-166. doi: 10.1038/s41579-018-0129-6. Nat Rev Microbiol. 2019. PMID: 30546113 Free PMC article. Review. - The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management.
Alfarouk KO, Bashir AHH, Aljarbou AN, Ramadan AM, Muddathir AK, AlHoufie STS, Hifny A, Elhassan GO, Ibrahim ME, Alqahtani SS, AlSharari SD, Supuran CT, Rauch C, Cardone RA, Reshkin SJ, Fais S, Harguindey S. Alfarouk KO, et al. Front Oncol. 2019 Feb 22;9:75. doi: 10.3389/fonc.2019.00075. eCollection 2019. Front Oncol. 2019. PMID: 30854333 Free PMC article. Review. - Helicobacter pylori-reflections for the next millennium.
Tytgat GN. Tytgat GN. Gut. 1999 Jul;45 Suppl 1(Suppl 1):I45-7. doi: 10.1136/gut.45.2008.i45. Gut. 1999. PMID: 10457037 Free PMC article. Review. No abstract available. - Helicobacter pylori in Native Americans in Northern Arizona.
Monroy FP, Brown HE, Sanderson PR, Jarrin G, Mbegbu M, Kyman S, Harris RB. Monroy FP, et al. Diseases. 2022 Mar 23;10(2):19. doi: 10.3390/diseases10020019. Diseases. 2022. PMID: 35466189 Free PMC article. - Helicobacter pylori: the size of the problem.
Parsonnet J. Parsonnet J. Gut. 1998 Jul;43 Suppl 1(Suppl 1):S6-9. doi: 10.1136/gut.43.2008.s6. Gut. 1998. PMID: 9764031 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical